feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouIndiaIndia
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Weight Loss Jabs: Gain Back Pounds Faster Than You Lose Them

Weight Loss Jabs: Gain Back Pounds Faster Than You Lose Them

8 Jan

•

Summary

  • Weight lost on jabs is regained within 20 months of stopping.
  • Weight regain after jabs is four times faster than traditional dieting.
  • Experts call for long-term support for users of weight loss drugs.
Weight Loss Jabs: Gain Back Pounds Faster Than You Lose Them

Individuals using popular weight loss injections are regaining lost weight significantly faster than previously understood, according to new research. A study published in the British Medical Journal indicates that patients stop taking weight loss drugs, such as semaglutide and tirzepatide, tend to regain lost pounds within 20 months of discontinuing treatment. This rebound effect is approximately four times quicker compared to individuals who achieve weight loss through lifestyle changes alone.

The research, analyzing data from over 9,000 participants across 37 studies, found that while patients on these medications lost an average of 8.3kg, they regained 4.8kg within the first year after stopping. Those on higher-dose medications like Wegovy and Mounjaro regained nearly 10kg in the first year. Cardiometabolic markers also returned to pre-treatment levels within 1.4 years.

trending

Islamabad suicide blast kills 31

trending

Vaibhav Suryavanshi scores 175

trending

Ronaldo trains with Al Nassr

trending

MRF profit doubles

trending

VTU adopts Artificial Super Intelligence

trending

RajaSaab OTT release on JioHotstar

trending

T20 World Cup opening ceremony

trending

Thakur captains Mumbai in Quarterfinal

trending

Riyan Parag scores fifty

Experts are now calling for comprehensive, long-term support for those using weight loss jabs. They suggest that obesity is a chronic condition, akin to high blood pressure, and may require lifelong treatment, whether through continued medication, behavioral support, or a combination of both. Without ongoing strategies, the effectiveness of these powerful drugs diminishes once treatment ceases.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
People tend to regain lost weight within 20 months of stopping these weight loss jabs.
Experts suggest that without the drug's effect on appetite regulation, overeating becomes more likely.
Experts recommend robust, long-term support, potentially including continued medication or behavioral changes.

Read more news on

Healthside-arrow

You may also like

Weight Loss Jab's Hidden Danger: Vision Loss Risk

1 day ago • 6 reads

article image

Weight Loss Drug Sparks Unexpected Pregnancies

1 Feb • 50 reads

article image

Knock-off Weight Drugs: Deadly Risks Exposed

30 Jan • 73 reads

article image

Weight-Loss Jabs Linked to Severe Pancreatitis Risk

30 Jan • 66 reads

article image

India's Weight-Loss Drug Boom: Patient Willingness Drives Market

3 Jan • 216 reads

article image